{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:07Z","timestamp":1792090027740,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["YXKC2022007"],"award-info":[{"award-number":["YXKC2022007"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2025ZZTS0966"],"award-info":[{"award-number":["2025ZZTS0966"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473229"],"award-info":[{"award-number":["82473229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2023CXQD058"],"award-info":[{"award-number":["2023CXQD058"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.celrep.2025.116530","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:28:55Z","timestamp":1762309735000},"page":"116530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diet-metabolism-transcription axis modulates the sensitivity to CDK4\/6 inhibitors through RB1 in prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"given":"Xurui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-6005","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116530_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2025.116530_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4111\/icu.20230333","article-title":"Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study","volume":"65","author":"Kim","year":"2024","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.celrep.2025.116530_bib3","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","article-title":"Treatment effects in prostate cancer","volume":"31","author":"Evans","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2025.116530_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2025.116530_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713618","article-title":"Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.116530_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153851","article-title":"Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation","volume":"233","author":"Faskhoudi","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.celrep.2025.116530_bib7","first-page":"232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2025.116530_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2025.116530_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","author":"Massagu\u00e9","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116530_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2025.116530_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O'Leary","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.116530_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103199","article-title":"The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives","volume":"157","author":"Brighi","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.celrep.2025.116530_bib13","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1158\/1078-0432.CCR-21-0024","article-title":"A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer","volume":"27","author":"Palmbos","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116530_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","article-title":"Mechanisms of Sensitivity and Resistance to CDK4\/6 Inhibition","volume":"37","author":"Alvarez-Fernandez","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116530_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tcb.2023.07.012","article-title":"Patterns in the tapestry of chromatin-bound RB","volume":"34","author":"Sanidas","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.celrep.2025.116530_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/annonc\/mdx784","article-title":"Polyclonal RB1 mutations and acquired resistance to CDK 4\/6 inhibitors in patients with metastatic breast cancer","volume":"29","author":"Condorelli","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2025.116530_bib18","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","article-title":"Obesity and Cancer Mechanisms: Cancer Metabolism","volume":"34","author":"Hopkins","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.116530_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrendo.2014.94","article-title":"Obesity and cancer--mechanisms underlying tumour progression and recurrence","volume":"10","author":"Park","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2025.116530_bib20","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-23-0519","article-title":"Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumour Microenvironment Remodeling in Prostate Cancer","volume":"84","author":"Boufaied","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123000","article-title":"Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity","volume":"3","author":"Iqbal","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2025.116530_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, Inflammation, and Cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.celrep.2025.116530_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050597","article-title":"Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression","volume":"8","author":"Narita","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.celrep.2025.116530_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s10020-024-00945-1","article-title":"Exosomes derived from apical papilla stem cells improve NASH by regulating fatty acid metabolism and reducing inflammation","volume":"30","author":"Nie","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.celrep.2025.116530_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumour efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116530_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11912-024-01540-7","article-title":"CDK4\/6 inhibitors: The Devil is in the Detail","volume":"26","author":"Magge","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.celrep.2025.116530_bib27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-21-4302","article-title":"A Phase Ib\/II Study of the CDK4\/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer","volume":"28","author":"de Kouchkovsky","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib28","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1078-0432.CCR-23-3436","article-title":"A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1","volume":"30","author":"Agarwal","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302368","article-title":"Targeting CBX3 with a Dual BET\/PLK1 Inhibitor Enhances the Antitumour Efficacy of CDK4\/6 Inhibitors in Prostate Cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2025.116530_bib30","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-23-3704","article-title":"CDK4\/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/71600","article-title":"Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas","volume":"6","author":"Higashitsuji","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116530_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-kappaB Activation and PD-L1 Expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.116530_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41418-024-01282-w","article-title":"Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer","volume":"31","author":"Ren","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2025.116530_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2015.09.010","article-title":"The role of the transcription factor Ets1 in carcinoma","volume":"35","author":"Dittmer","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2025.116530_bib35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/aja.2012.107","article-title":"Overexpression of ETS-1 is associated with malignant biological features of prostate cancer","volume":"14","author":"Li","year":"2012","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.celrep.2025.116530_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41598-023-50700-5","article-title":"Allele-specific effect of various dietary fatty acids and ETS1 transcription factor on SCD1 expression","volume":"14","author":"Tibori","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2025.116530_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103458","article-title":"Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer","volume":"79","author":"Jog","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.celrep.2025.116530_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2867-10-8","article-title":"A cancer derived mutation in the retinoblastoma gene with a distinct defect for LXCXE dependent interactions","volume":"10","author":"Henley","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.celrep.2025.116530_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.768606","article-title":"Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells","volume":"13","author":"Saito","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116530_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.plipres.2008.01.002","article-title":"Transcriptional regulation of phosphatidylcholine biosynthesis","volume":"47","author":"Sugimoto","year":"2008","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.celrep.2025.116530_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.celrep.2025.116530_bib42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y","article-title":"Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae","volume":"14","author":"Daum","year":"1998","journal-title":"Yeast"},{"key":"10.1016\/j.celrep.2025.116530_bib43","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/ijms14022529","article-title":"Regulation of Phosphatidylethanolamine Homeostasis\u2014The Critical Role of CTP:Phosphoethanolamine Cytidylyltransferase (Pcyt2)","volume":"14","author":"Pavlovic","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.116530_bib44","article-title":"PCYT2 mediates ovarian epithelial cancer metastasis by regulating cell membrane fluidity through the AMPK\/FOXO1 signalling pathway","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2025.116530_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumour microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.celrep.2025.116530_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41392-024-01771-x","article-title":"Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2025.116530_bib47","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3389\/fimmu.2018.02649","article-title":"Inflammatory Links Between High Fat Diets and Diseases","volume":"9","author":"Duan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116530_bib48","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.7150\/thno.56157","article-title":"High fat diet, gut microbiome and gastrointestinal cancer","volume":"11","author":"Tong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.celrep.2025.116530_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2096328","article-title":"Obesity enriches for tumour protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC","volume":"14","author":"Kesh","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.celrep.2025.116530_bib50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","article-title":"Fasting-mimicking diet and hormone therapy induce breast cancer regression","volume":"583","author":"Caffa","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116530_bib51","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early Adaptation and Acquired Resistance to CDK4\/6 Inhibition in Estrogen Receptor-Positive Breast Cancer","volume":"76","author":"Herrera-Abreu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib52","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","article-title":"HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4\/6 Inhibitor Resistance in Cancer","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110336","article-title":"DAB2IP regulates intratumour al testosterone synthesis and CRPC tumour growth by ETS1\/AKR1C3 signaling","volume":"95","author":"Gu","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.celrep.2025.116530_bib54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/carcin\/bgs007","article-title":"ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype","volume":"33","author":"Smith","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.celrep.2025.116530_bib55","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbrc.2011.12.047","article-title":"ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression","volume":"417","author":"Kato","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2025.116530_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.116530_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41419-022-05022-1","article-title":"Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma","volume":"13","author":"Vishnoi","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2025.116530_bib58","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.nut.2014.04.013","article-title":"Lysophospholipid profile in serum and liver by high-fat diet and tumour induction in obesity-resistant BALB\/c mice","volume":"30","author":"Kim","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.celrep.2025.116530_bib59","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.2147\/DMSO.S337979","article-title":"Analysis of Serum Metabolomics in Obese Mice Induced by High-Fat Diet","volume":"14","author":"Bao","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.celrep.2025.116530_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12944-021-01437-5","article-title":"Identification of lipidomic profiles associated with drug-resistant prostate cancer cells","volume":"20","author":"Ingram","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.celrep.2025.116530_bib61","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ijc.32314","article-title":"Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC","volume":"146","author":"Schmidt","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2025.116530_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102826","article-title":"WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury","volume":"65","author":"Deng","year":"2023","journal-title":"Redox Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725013014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725013014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:27:13Z","timestamp":1776918433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725013014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2211124725013014"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116530","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet-metabolism-transcription axis modulates the sensitivity to CDK4\/6 inhibitors through RB1 in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116530"}}